Clinical Study Results
How many participants had serious adverse reactions?
There were 3.3% of participants in this study who had serious adverse
reactions. This was 5 out of 151 participants.
The table below shows the serious adverse reactions the participants had
during this study. None of the participants died during this study.
Serious adverse reactions
5 mg of 10 mg of
dapagliflozin + dapagliflozin +
insulin insulin Total
(Out of 76 (Out of 75 (Out of 151
participants) participants) participants)
Too much acid in the
2.6% (2) 1.3% (1) 2.0% (3)
blood from diabetes
Pregnancy miscarriage 1.3% (1) 0.0% (0) 0.7% (1)
Coma from low blood
0.0% (0) 1.3% (1) 0.7% (1)
sugar levels
How many participants had adverse reactions?
There were 29.8% of participants who had adverse reactions during this study.
This was 45 out of 151 participants.
There were 5.3% of participants who stopped taking dapagliflozin because of
adverse reactions they had during this study. This was 8 out of 151 participants.
5